Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$699.2K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| -52.3% |
| Open the original filing on SEC.gov |
| Sep 14 | PBYI | Puma Biotechnology, INC. | MEXER◷ | 50,000 | $2.93 | $146.5K | +72.6% | Open the original filing on SEC.gov |
| Jun 11 | PBYI | Puma Biotechnology, INC. | AGRANT | 27,000 | — | — | +64.5% | Open the original filing on SEC.gov |
| Jan 12 | ZYME | Zymeworks Inc. | AGRANT◆ | 7,700 | — | — | — | Open the original filing on SEC.gov |
| Jan 12 | ZYME | Zymeworks Inc. | AGRANT◆ | 11,500 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | SMMT | Summit Therapeutics Inc. | AGRANT◆ | 3,219 | $8.76 | $28.2K | — | Open the original filing on SEC.gov |
| Jan 2 | SMMT | Summit Therapeutics Inc. | AGRANT◆ | 35,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 18, 2025 | PBYI | Puma Biotechnology, INC. | SSELL◷ | 27,000 | $3.37 | $90.9K | -39.2% | Open the original filing on SEC.gov |
| Jun 13, 2025 | PBYI | Puma Biotechnology, INC. | SSELL◷ | 12,150 | $3.40 | $41.3K | -15.0% | Open the original filing on SEC.gov |
| Jun 11, 2025 | PBYI | Puma Biotechnology, INC. | AGRANT | 27,000 | — | — | +50.0% | Open the original filing on SEC.gov |